REVIEW
|
doi:10.20944/preprints201909.0071.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Sorafenib; hepatocellular carcinoma; prognostic factors; predicitve factors
Online: 6 September 2019 (10:32:29 CEST)